DD
48
3
SYY
50
6
MTB
46
2
BWA
33
-8
LMT
37
-2
D
32
-5
SRCL
70
12
FRT
36
-9
HON
57
4
ROST
75
3
ADBE
62
-2
VLO
35
2
SHW
61
3
GE
65
8
CNP
62
-3
CNX
36
-4
MMM
25
-3
SRE
28
-5
UNM
56
4
EBAY
39
4
DD
48
3
SYY
50
6
MTB
46
2
BWA
33
-8
LMT
37
-2
D
32
-5
SRCL
70
12
FRT
36
-9
HON
57
4
ROST
75
3
ADBE
62
-2
VLO
35
2
SHW
61
3
GE
65
8
CNP
62
-3
CNX
36
-4
MMM
25
-3
SRE
28
-5
UNM
56
4
EBAY
39
4
Financhill
Back

Beyond Meat Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
37

BYND
Beyond Meat

Last Price:
6.49
Seasonality Move:
-14.07%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.15
Seasonality Move:
3.65%
Sell
37
Beyond Meat (BYND) is a Sell

Is Beyond Meat a Buy, Sell or Hold?

  • The current Beyond Meat [BYND] share price is $6.49. The Score for BYND is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • BYND is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BYND Stock Price Chart

What is Beyond Meat's stock price today?

  • The Beyond Meat share price today is $6.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BYND is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

BYND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.14 Sell
Relative Strength Index (14 RSI): 34.89 Sell
Chaikin Money Flow: 992511 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (6.96 - 7.7) Sell
Bollinger Bands (100): (6.58 - 8.22) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

BYND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 7.09 Sell
20-day SMA: 7.26 Sell
50-day SMA: 7.13 Sell
200-day SMA: 7.89 Sell
8-day EMA: 6.95 Sell
20-day EMA: 7.18 Sell
50-day EMA: 7.3 Sell
200-day EMA: 8.88 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Beyond Meat Earnings Growth & BYND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.16 per share, an increase this year of $1.52 per share, and an increase next year of $0.47 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Beyond Meat Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):